Report Detail

Medical Devices & Consumables Global and United States IVD Antibody Market Report & Forecast 2022-2028

  • RnM4447876
  • |
  • 31 May, 2022
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Summary:

IVD Antibody
Market Analysis and Insights: Global and United States IVD Antibody Market
This report focuses on global and United States IVD Antibody market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global IVD Antibody market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, mAb accounting for % of the IVD Antibody global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, RIA was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the IVD Antibody market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global IVD Antibody Scope and Market Size
IVD Antibody market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global IVD Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the IVD Antibody market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the IVD Antibody market is segmented into
mAb
pAb
rAbs
Segment by Application, the IVD Antibody market is segmented into
RIA
ELISA
CLIA
LFIA
Other
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and IVD Antibody Market Share Analysis
IVD Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in IVD Antibody business, the date to enter into the IVD Antibody market, IVD Antibody product introduction, recent developments, etc.
The major vendors covered:
BD PharMingen
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana


Table of Contents

    1 Study Coverage

    • 1.1 IVD Antibody Product Introduction
    • 1.2 Global IVD Antibody Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global IVD Antibody Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global IVD Antibody Sales in Volume for the Year 2017-2028
    • 1.3 United States IVD Antibody Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States IVD Antibody Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States IVD Antibody Sales in Volume for the Year 2017-2028
    • 1.4 IVD Antibody Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States IVD Antibody in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of IVD Antibody Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 IVD Antibody Market Dynamics
      • 1.5.1 IVD Antibody Industry Trends
      • 1.5.2 IVD Antibody Market Drivers
      • 1.5.3 IVD Antibody Market Challenges
      • 1.5.4 IVD Antibody Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 IVD Antibody Market Segment by Type
      • 2.1.1 mAb
      • 2.1.2 pAb
      • 2.1.3 rAbs
    • 2.2 Global IVD Antibody Market Size by Type
      • 2.2.1 Global IVD Antibody Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global IVD Antibody Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global IVD Antibody Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States IVD Antibody Market Size by Type
      • 2.3.1 United States IVD Antibody Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States IVD Antibody Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States IVD Antibody Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 IVD Antibody Market Segment by Application
      • 3.1.1 RIA
      • 3.1.2 ELISA
      • 3.1.3 CLIA
      • 3.1.4 LFIA
      • 3.1.5 Other
    • 3.2 Global IVD Antibody Market Size by Application
      • 3.2.1 Global IVD Antibody Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global IVD Antibody Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global IVD Antibody Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States IVD Antibody Market Size by Application
      • 3.3.1 United States IVD Antibody Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States IVD Antibody Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States IVD Antibody Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global IVD Antibody Competitor Landscape by Company

    • 4.1 Global IVD Antibody Market Size by Company
      • 4.1.1 Top Global IVD Antibody Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global IVD Antibody Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global IVD Antibody Sales by Manufacturer (2017-2022)
      • 4.1.4 Global IVD Antibody Price by Manufacturer (2017-2022)
    • 4.2 Global IVD Antibody Concentration Ratio (CR)
      • 4.2.1 IVD Antibody Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of IVD Antibody in 2021
      • 4.2.3 Global IVD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global IVD Antibody Manufacturing Base Distribution, Product Type
      • 4.3.1 Global IVD Antibody Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers IVD Antibody Product Type
      • 4.3.3 Date of International Manufacturers Enter into IVD Antibody Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States IVD Antibody Market Size by Company
      • 4.5.1 Top IVD Antibody Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States IVD Antibody Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States IVD Antibody Sales by Players (2020, 2021 & 2022)

    5 Global IVD Antibody Market Size by Region

    • 5.1 Global IVD Antibody Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global IVD Antibody Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global IVD Antibody Sales in Volume by Region: 2017-2022
      • 5.2.2 Global IVD Antibody Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global IVD Antibody Market Size in Value by Region (2017-2028)
      • 5.3.1 Global IVD Antibody Sales in Value by Region: 2017-2022
      • 5.3.2 Global IVD Antibody Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America IVD Antibody Market Size YoY Growth 2017-2028
      • 6.1.2 North America IVD Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific IVD Antibody Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific IVD Antibody Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe IVD Antibody Market Size YoY Growth 2017-2028
      • 6.3.2 Europe IVD Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America IVD Antibody Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America IVD Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa IVD Antibody Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa IVD Antibody Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 BD PharMingen
      • 7.1.1 BD PharMingen Corporation Information
      • 7.1.2 BD PharMingen Description and Business Overview
      • 7.1.3 BD PharMingen IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 BD PharMingen IVD Antibody Products Offered
      • 7.1.5 BD PharMingen Recent Development
    • 7.2 Abcam
      • 7.2.1 Abcam Corporation Information
      • 7.2.2 Abcam Description and Business Overview
      • 7.2.3 Abcam IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Abcam IVD Antibody Products Offered
      • 7.2.5 Abcam Recent Development
    • 7.3 R&D Systems
      • 7.3.1 R&D Systems Corporation Information
      • 7.3.2 R&D Systems Description and Business Overview
      • 7.3.3 R&D Systems IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 R&D Systems IVD Antibody Products Offered
      • 7.3.5 R&D Systems Recent Development
    • 7.4 Cell Signaling Technology
      • 7.4.1 Cell Signaling Technology Corporation Information
      • 7.4.2 Cell Signaling Technology Description and Business Overview
      • 7.4.3 Cell Signaling Technology IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Cell Signaling Technology IVD Antibody Products Offered
      • 7.4.5 Cell Signaling Technology Recent Development
    • 7.5 Affymatrix
      • 7.5.1 Affymatrix Corporation Information
      • 7.5.2 Affymatrix Description and Business Overview
      • 7.5.3 Affymatrix IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Affymatrix IVD Antibody Products Offered
      • 7.5.5 Affymatrix Recent Development
    • 7.6 BioLegend
      • 7.6.1 BioLegend Corporation Information
      • 7.6.2 BioLegend Description and Business Overview
      • 7.6.3 BioLegend IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 BioLegend IVD Antibody Products Offered
      • 7.6.5 BioLegend Recent Development
    • 7.7 Santa Cruz Biotechnologies
      • 7.7.1 Santa Cruz Biotechnologies Corporation Information
      • 7.7.2 Santa Cruz Biotechnologies Description and Business Overview
      • 7.7.3 Santa Cruz Biotechnologies IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Santa Cruz Biotechnologies IVD Antibody Products Offered
      • 7.7.5 Santa Cruz Biotechnologies Recent Development
    • 7.8 Beckman Coulter
      • 7.8.1 Beckman Coulter Corporation Information
      • 7.8.2 Beckman Coulter Description and Business Overview
      • 7.8.3 Beckman Coulter IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Beckman Coulter IVD Antibody Products Offered
      • 7.8.5 Beckman Coulter Recent Development
    • 7.9 Roche/Ventana
      • 7.9.1 Roche/Ventana Corporation Information
      • 7.9.2 Roche/Ventana Description and Business Overview
      • 7.9.3 Roche/Ventana IVD Antibody Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Roche/Ventana IVD Antibody Products Offered
      • 7.9.5 Roche/Ventana Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 IVD Antibody Industry Chain Analysis
    • 8.2 IVD Antibody Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 IVD Antibody Distributors
    • 8.3 IVD Antibody Production Mode & Process
    • 8.4 IVD Antibody Sales and Marketing
      • 8.4.1 IVD Antibody Sales Channels
      • 8.4.2 IVD Antibody Distributors
    • 8.5 IVD Antibody Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on IVD Antibody. Industry analysis & Market Report on IVD Antibody is a syndicated market report, published as Global and United States IVD Antibody Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of IVD Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      3,076.15
      6,152.30
      3,592.05
      7,184.10
      598,867.50
      1,197,735.00
      320,820.50
      641,641.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report